Cover Image
市場調查報告書

藥物濫用抑制、治療:技術的評估,競爭環境,及R&D情形

Substance Abuse Deterrents and Treatments - An Assessment of the Technological, Competitive and R&D Landscape

出版商 CBR Pharma Insights 商品編碼 356366
出版日期 內容資訊 英文 73 Pages
訂單完成後即時交付
價格
Back to Top
藥物濫用抑制、治療:技術的評估,競爭環境,及R&D情形 Substance Abuse Deterrents and Treatments - An Assessment of the Technological, Competitive and R&D Landscape
出版日期: 2016年03月16日 內容資訊: 英文 73 Pages
簡介

本報告提供全球藥物濫用抑制、治療市場上技術,競爭情形及R&D形勢相關的總括性調查,上市藥、開發平台藥物,最有前途的商業性領域,及主要商機等相關詳細分析。

簡介

藥物濫用:全球趨勢、規定的發展

  • 違法藥物的濫用:全球的趨勢
  • 全球違法藥物濫用數趨勢
  • 全球酒精、尼古丁的攝取、中毒趨勢
  • 全球注射的藥物的使用、HIV感染趨勢
  • 聯合國的藥物濫用的國際指南的開發
  • 藥物濫用的管理上國際毒品統一控制委員會 (INCB) 所扮演的角色
  • 解決全球藥物濫用的法規、方法的差異、其他

藥物濫用抑制產品開發的技術

  • 濫用抑制處方技術:主要的優點
  • 對濫用抑制處方的限制與引進的討論
  • 濫用抑制處方策略
  • 案例研究

適合藥物濫用治療的上市產品

  • 已上市的治療藥:各中毒類型
  • 在藥物濫用治療市場活動的企業數量:各中毒類型
  • 商業化層級最高藥物濫用治療藥
  • 用藥物濫用已上市治療藥數最許多企業
  • 在全球有寬廣的存在感的主要企業
  • 主要國家的競爭分析、產品情形分析
  • 主要上市產品的清單:各中毒類型
  • 上市產品的主要的給藥途徑:各中毒類型

適合藥物濫用治療的開發中產品

  • 開發平台治療藥數:各組織類型
  • 開發平台治療藥數:各中毒類型
  • 開發平台治療藥數最多的企業
  • 開發平台治療藥數:各開發階段
  • 後期開發階段開發中產品簡介
  • 開發平台治療藥數:各分子類型、給藥途徑

未來的治療情形

  • 參考資料
目錄
Product Code: GBI066CBR

Summary

GBI Research's latest report, "Substance Abuse Deterrents and Treatments - An Assessment of the Technological, Competitive and R&D Landscape", discusses global trends in the substance abuse deterrents and addiction treatments market including the impact substance abuse is having on local economies, healthcare systems and society as a whole. This new report provides analyses of current unmet medical needs as well as an in-depth review and assessment of technologies being employed by pharmaceutical manufacturers to reduce the risk of prescription drug misuse and abuse. A series of detailed case studies showcase novel abuse deterrent formulations (ADFs) that have been recently adopted by manufacturers of commonly abused prescription drugs. Although these technologies are relatively nascent, we expect the ADF field to grow rapidly in the coming years driven by strong demand and local government support within many key markets.

Information leveraged from our robust industry-leading database shows a diverse range of drug therapies currently in development for the treatment of substance abuse and addiction, with various novel approaches under investigation. Our new study provides multilevel analysis of both the R&D and marketed product landscape including data and analyses by addiction type, molecule, stage of development, route of administration, company, geographical presence and many other insightful and pertinent analytics. Additionally, the report includes our predictions on the future treatment landscape.

GBI Research conducted extensive research efforts in order to provide a comprehensive view of the technological, competitive and R&D landscape of the substance abuse deterrents and treatments market. This new report adds to our unique portfolio of trusted industry analyses that enable our clients to assess the most promising commercial areas in the market and exploit key business opportunities.

Scope

  • How does substance abuse impact individuals, society, the economy and healthcare systems?
  • What are the most pertinent commercial trends in the substance abuse deterrents and treatments market?
  • What are the most pressing medical needs yet to be addressed regarding substance abuse and addiction?
  • What are the most recent advances in abuse deterrent formulation technology?

Marketed products for the treatment of substance abuse and addiction

  • What are the products with the highest degree of commercialization?
  • What are the indications with the highest volume of marketed products?
  • What are the main segments of interest for companies operating in the substance abuse treatments market?
  • Who are the leading companies, with the highest volume of products in the market and with the widest geographical presence?
  • What are the most prevalent routes of administration of products in the market?

Pipeline therapies for the treatment of substance abuse and addiction

  • What role are universities and research institutions playing in the development of novel therapies?
  • What indications have the largest number of therapies in development?
  • Which companies have the largest portfolios of therapies in development?
  • Which therapies are expected to treat multiple indications?
  • In which stage of development are most of the pipeline therapies currently concentrated?
  • Which types of molecules and routes of administration currently dominate the substance abuse therapies pipeline?
  • How will the product and competitive landscape be redefined by the expected launch of novel therapies in the coming years?

Key Reasons to Purchase

This report will allow you to -

  • Gain insightful analyses and understanding of market dynamics: This report comprehensively describes and assesses the most pertinent commercial, technological, and innovative aspects of the substance abuse deterrents and treatments market.
  • Assess marketed and pipeline products for treating substance abuse and addiction: Our new study provides multilevel analyses of the key products currently available for treating various substance abuse addictions as well as promising candidates currently in development.
  • Understand current unmet medical needs: This report provides insights regarding the impact substance abuse can have on individuals and society as whole as well as an in-depth gap analysis that helps to identify to the most pressing medical needs yet to be addressed.
  • Assess advances in drug deterrent technology, their advantages and their limitations: This report assesses current and novel formulation strategies being implemented by drug manufacturers to reduce the risk of prescription misuse and abuse. Analyses include key advantages, limitations as well as arguments for and against their adoption.
  • Assess global trends prevailing in the field of substance abuse deterrents and treatments: This report describes trends at a global level regarding drug use prevalence, regulations and guidelines, as well as the different approaches being taken in different countries to tackle this global issue.

Table of Contents

Introduction

  • Overview: Substance Abuse, Deterrence and Treatments
  • Contributing Factors of Drug Abuse and Addiction
  • Commonly Abused Substances
  • Prescription or OTC Substance Abuse
  • Common Effects and Symptoms of Substance Abuse
  • Substance Abuse and Brain Function
  • Health, Social and Economic Impact of Substance Abuse
  • Impact of Substance Abuse on Specific Population Groups

Substance Abuse: Global Trends and Regulatory Developments

  • Illicit Substance Abuse: Global Trends
  • Trends in Global Number of Abusers of Illicit Drugs
  • Global Trends in Alcohol and Nicotine Use and Addiction
  • Global Trends in Injecting Drug Use and HIV Infection
  • International Guidelines Developed by the UN for Abusable Substances
  • The Role of the International Narcotics Control Board in Controlling Substance Abuse
  • Worldwide Differences in Regulations and Approaches to Tackle Substance Abuse <>Unmet Medical Need Analysis and Gaps in the Treatment of Substance abuse

Technologies for Developing Abuse Deterrent Products

  • Abuse Deterrent Formulation Technologies: Key Advantages
  • Limitations of Abuse Deterrent Formulations and Arguments Against Adoption
  • Abuse Deterrent Formulation Strategies
  • Case Studies
    • Embeda
    • Suboxone
    • INTAC technology
    • DETERx technology
    • Osmotic extended-release oral delivery system
    • Aversion Technology
    • iCRT-deter
    • Prodrug Combined with MPAR Technology

Marketed Products For the Treatment of Substance Abuse

  • Marketed Therapies by Type of Addiction
  • Volume of Companies Operating in the Substance Abuse Treatment Market by Type of Addiction
  • Substance Abuse Therapies with Highest Degree of Commercialization
  • Companies with Highest Volume of Marketed Therapies for Substance Abuse
  • Key Companies with a Wide Global Presence
  • Competitive and Product Landscape Analysis in Key Countries
  • Lists of Key Marketed Products by Type of Addiction
  • Key Routes of Administration of Marketed Products by Type of Addiction

Pipeline Products For the Treatment of Substance Abuse

  • Volume of Pipeline Therapies by Type of Organization
  • Volume of Pipeline Therapies by Type of Addiction
  • Organizations with the Highest Volume of Pipeline Therapies
  • Volume of Pipeline Therapies by Stage of Development
  • Profiles of Late Stage Pipeline Products
  • Volume of Pipeline Therapies by Type of Molecule and Route of Administration

Future Treatment Landscape

  • Bibliography
Back to Top